Delivery Order SPE2DB24D9238-SPE2DB25FDQED

Award Date 10/17/24
Potential Completion Date 10/18/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 5, 2024, is for the delivery of XTANDI 80 MG TABLET 60S, a pharmaceutical product. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $25,868.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical...
The Defense Logistics Agency (DLA) awarded a $4,311.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,321.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has an ultimate completion date of August 1, 2022, is for the supply of 4557937756 - XTANDI 40 MG CAPSULE 120S. This award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group, which runs...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to place orders for a comprehensive range of pharmaceutical products to support the medical...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $43,113.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S and has a period of performance through May 30, 2024. This Delivery Order contract is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA, valued at up to $499,999,999, which...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $34,490.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 120 count bottles of the prescription drug XTANDI 40 MG CAPSULE, with a completion date of June 11, 2024. This delivery order is placed against a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc....
The U.S. Defense Logistics Agency (DLA) awarded a $4,311.35 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a specialized pharmaceutical product, with a period of performance through March 26, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $8,339.18 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 tablets of the pharmaceutical drug Xtandi (40 mg), with a completion date of February 26, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,508.77 contract is for the delivery of XTANDI 80 MG TABLET 60S, a specialized prescription medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB24D9238
    Indefinite Delivery Contract
  • SPE2DB24D9238-SPE2DB25FDQED
    Delivery Order

The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,134,628 units of the prescription medication XTANDI 80 MG TABLET 60S, with a completion date of October 18, 2024.

DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

Generated 1/16/25, 9:21 AM